Literature DB >> 15222753

Residue 259 in protein-tyrosine phosphatase PTP1B and PTPalpha determines the flexibility of glutamine 262.

Günther H Peters1, Lars F Iversen, Henrik S Andersen, Niels Peter H Møller, Ole H Olsen.   

Abstract

To study the flexibility of the substrate-binding site and in particular of Gln262, we have performed adiabatic conformational search and molecular dynamics simulations on the crystal structure of the catalytic domain of wild-type protein-tyrosine phosphatase (PTP) 1B, a mutant PTP1B(R47V,D48N,M258C,G259Q), and a model of the catalytically active form of PTPalpha. For each molecule two cases were modeled: the Michaelis-Menten complex with the substrate analogue p-nitrophenyl phosphate (p-PNPP) bound to the active site and the cysteine-phosphor complex, each corresponding to the first and second step of the phosphate hydrolysis. Analyses of the trajectories revealed that in the cysteine-phosphor complex of PTP1B, Gln262 oscillates freely between the bound phosphate group and Gly259 frequently forming, as observed in the crystal structure, a hydrogen bond with the backbone oxygen of Gly259. In contrast, the movement of Gln262 is restricted in PTPalpha and the mutant due to interactions with Gln259 reducing the frequency of the oscillation of Gln262 and thereby delaying the positioning of this residue for the second step in the catalysis, as reflected experimentally by a reduction in k(cat). Additionally, in the simulation with the Michaelis-Menten complexes, we found that a glutamine in position 259 induces steric hindrance by pushing the Gln262 side chain further toward the substrate and thereby negatively affecting K(m) as indicated by kinetic studies. Detailed analysis of the water structure around Gln262 and the active site Cys215 reveals that the probability of finding a water molecule correctly positioned for catalysis is much larger in PTP1B than in PTP1B(R47V,D48N,M258C,G259Q) and PTPalpha, in accordance with experiments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222753     DOI: 10.1021/bi0498757

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Biochemical, Enzymatic, and Computational Characterization of Recurrent Somatic Mutations of the Human Protein Tyrosine Phosphatase PTP1B in Primary Mediastinal B Cell Lymphoma.

Authors:  Rongxing Liu; Yujie Sun; Jérémy Berthelet; Linh-Chi Bui; Ximing Xu; Mireille Viguier; Jean-Marie Dupret; Frédérique Deshayes; Fernando Rodrigues Lima
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

2.  Molecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.

Authors:  Lars Linderoth; Thomas L Andresen; Kent Jørgensen; Robert Madsen; Günther H Peters
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

3.  Characterization of Protein Tyrosine Phosphatase 1B Inhibition by Chlorogenic Acid and Cichoric Acid.

Authors:  James M Lipchock; Heidi P Hendrickson; Bonnie B Douglas; Kelly E Bird; Patrick S Ginther; Ivan Rivalta; Nicholas S Ten; Victor S Batista; J Patrick Loria
Journal:  Biochemistry       Date:  2016-12-27       Impact factor: 3.162

4.  Evolutionary mechanisms driving the evolution of a large polydnavirus gene family coding for protein tyrosine phosphatases.

Authors:  Céline Serbielle; Stéphane Dupas; Elfie Perdereau; François Héricourt; Catherine Dupuy; Elisabeth Huguet; Jean-Michel Drezen
Journal:  BMC Evol Biol       Date:  2012-12-27       Impact factor: 3.260

5.  A Novel PTP1B Inhibitor-Phosphate of Polymannuronic Acid Ameliorates Insulin Resistance by Regulating IRS-1/Akt Signaling.

Authors:  Dan Li; Shuai Zhang; Cheng Yang; Quancai Li; Shixin Wang; Ximing Xu; Jiejie Hao; Chunxia Li
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.